Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2005
12/29/2005US20050287142 Remedies or preventives for rheumatoid arthritis
12/29/2005US20050287141 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
12/29/2005US20050287140 Antibodies to angiogenesis inhibiting domains of CD148
12/29/2005US20050287139 Wound healing
12/29/2005US20050287138 CCR4-specific antibody composition
12/29/2005US20050287137 Novel composition
12/29/2005US20050287136 human cytotoxic T-lymphocyte antigen 4 (CTLA-4); heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4; administering an antibody or antigen-binding portion to treat a tumor
12/29/2005US20050287118 Bacterial plasmid with immunological adjuvant function and uses thereof
12/29/2005US20050287066 Anti-rat angiotensin I-converting enzyme (ACE, CD143) monoclonal antibodies and uses thereof
12/29/2005DE102004024617A1 Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung Differentially expressed in tumors gene products and their use
12/29/2005CA2847677A1 Methods for treating conditions associated with masp-2 dependent complement activation
12/29/2005CA2573144A1 Methods for treating conditions associated with masp-2 dependent complement activation
12/29/2005CA2571404A1 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
12/29/2005CA2570510A1 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same
12/29/2005CA2570395A1 Antibodies binding to cd34+/cd36+ fetal but not to adult cells
12/29/2005CA2570267A1 Fgfr binding peptides
12/29/2005CA2570130A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
12/29/2005CA2570034A1 Diagnosis and treatment of siglec-6 associated diseases
12/29/2005CA2570017A1 Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent
12/29/2005CA2569867A1 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation
12/29/2005CA2568570A1 Method of treating granuloma annulare or sarcoid
12/29/2005CA2567129A1 Antibodies against human interleukin-13 and uses therefor
12/28/2005EP1610127A1 N1,n12-diacetylspermine as tumor marker
12/28/2005EP1609870A1 Method of diagnosing lawsonia intracellularis
12/28/2005EP1609865A2 Hepatitis B virus (HBV) variants
12/28/2005EP1609864A2 Use of neuronal apoptosis inhibitor protein (NAIP)
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609860A1 Seb modification and preventive/remedy for diseases with immune abnormality contianing the same
12/28/2005EP1609856A2 Brain or heart cyclic nucleotide gated ion channel compounds and uses thereof
12/28/2005EP1609854A1 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same
12/28/2005EP1609853A1 Process for controlling sialylation of proteins produced by mammalian cell culture
12/28/2005EP1609804A1 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1608984A2 Gastrin hormone immunoassays
12/28/2005EP1608970A2 Ccn3 compositions and methods
12/28/2005EP1608967A2 Compositions and methods for the diagnosis and treatment of tumor
12/28/2005EP1608782A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
12/28/2005EP1608776A2 Methods for monitoring drug activities in vivo
12/28/2005EP1608756A2 Staphylococcus epidermidis antigens
12/28/2005EP1608743A2 Phosphodiesterase 10a7 isoforms and methods of use
12/28/2005EP1608730A2 Truncated baff receptors
12/28/2005EP1608684A2 Amphiregulin antibodies and their use to treat cancer and psoriasis
12/28/2005EP1608683A1 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
12/28/2005EP1608404A2 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18)
12/28/2005EP1608399A2 Ligands for tgf--beta binding proteins and uses thereof
12/28/2005EP1608321A2 Cytokine-expressing cellular vaccine combinations
12/28/2005EP1608316A2 Methods and compositions for treating and preventing inflammatory conditions
12/28/2005EP1608307A2 An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
12/28/2005EP1461300A4 Antibodies against monocyte chemotactic proteins
12/28/2005EP1221482B1 Hemopoietin receptor protein, nr12
12/28/2005EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides
12/28/2005EP1123114B1 Virus-like particles for the induction of autoantibodies
12/28/2005EP1073683B1 G-csf receptor agonist antibodies and screening method therefor
12/28/2005EP1025227B1 Human toll homologues
12/28/2005EP1025129B1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan
12/28/2005EP0971959B1 Humanized antibodies and methods for forming humanized antibodies
12/28/2005EP0925356B1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/28/2005EP0859840B1 Biologically active eph family ligands
12/28/2005EP0716609B1 Methods and compositions for stimulating and inhibiting tgf-beta activity
12/28/2005EP0682529B2 Antibody for the treatment of insulin dependent diabetes
12/28/2005EP0646175B1 Recombinant pseudomonas exotoxin with increased activity
12/28/2005EP0642585B1 Activation of oligomerizing receptors by using fused receptor ligands
12/28/2005CN1714151A Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
12/28/2005CN1714150A Genetic products differentially expressed in tumors and the use thereof
12/28/2005CN1714148A Viral deconstruction through capsid assembly in vitro
12/28/2005CN1714147A Method of obtaining cell lines in a protein-free medium and cell lines thus obtained
12/28/2005CN1233830C China bee and hornet hemolysis peptide precursor gene and coded polypeptide and preparing method
12/28/2005CN1233828C Antihuman hemoglobin detection reagent strips and monoclone antibody contained therewith
12/28/2005CN1233417C Peptide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
12/28/2005CA2569200A1 Humanized anti-tag-72 monoclonal antibodies
12/27/2005US6979733 Comprises nucleotide sequences coding biocatalyst polypeptide for hydrolysis of epoxides and arene oxides into diols such as glycidol and atenolol; antiinflammatory/hypotensive agents
12/27/2005US6979730 Nucleic acids encoding prostate stem cell antigen
12/27/2005US6979726 Immunoconjugates
12/27/2005US6979557 Comprise olignucleotide sequences associated with translation initiation for analyzing the function of polypeptide
12/27/2005US6979556 Expression vector coding preferential immunoglobulin for use as tool in human terapeutic and gene transfer
12/27/2005US6979555 Hyaluronan receptor for endocytosis
12/27/2005US6979547 Methods for designing specific ion channel blockers
12/27/2005US6979546 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
12/27/2005US6979534 Compositions and methods for detection of antibody binding to cells
12/27/2005US6979449 Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis
12/27/2005US6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/27/2005US6979443 Chemokine α-6
12/27/2005CA2137280C Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
12/22/2005WO2005121797A2 Screening method using antibody heavy chains
12/22/2005WO2005121789A1 Identification of antibody-producing cells
12/22/2005WO2005121341A1 Tumor specific antibody
12/22/2005WO2005121339A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005WO2005121338A1 Anti-perp antibody
12/22/2005WO2005121325A1 Heart and skeletal muscle inflammation (hsmi) virus
12/22/2005WO2005121180A1 Humanized anti-tag-72 monoclonal antibodies
12/22/2005WO2005121179A2 Transferrin receptor antibodies
12/22/2005WO2005121178A2 Immunoaffinity chromatography polyol-responsive monoclonal antibodies
12/22/2005WO2005121177A2 Anti-il-13 antibodies, crystals of anti-il-13 antibodies and complexes comprising them
12/22/2005WO2005121175A2 Env polypeptide complexes and methods of use
12/22/2005WO2005121170A1 Abc transporter protein that confers resistance to bacitracin in interococci
12/22/2005WO2005121166A1 Novel immunointeractive molecules and uses thereof
12/22/2005WO2005121165A1 Process for protein isolation
12/22/2005WO2005120638A1 Combination of radio waves and pharmacologically active substances
12/22/2005WO2005120583A2 Method for preventing or treating cardiac hypertrophy
12/22/2005WO2005120571A2 Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation
1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 1494